Steroids and Insulin Resistance: Can Prednisone and Other Steroids Raise Blood Sugar?
Steroid medications help many people. They are used for asthma, allergies, joint inflammation, autoimmune conditions, skin disorders, and many other problems. But there is an important metabolic side effect that deserves more attention: some steroids can increase insulin resistance and raise blood sugar.
That matters because insulin resistance often develops quietly. A person may not feel dramatically different, yet important metabolic changes may already be taking place. This is one reason the topic is timely. Peter Attia’s recent content continues to emphasize early detection of insulin resistance and broader metabolic health, showing that the issue is receiving current attention among health educators and clinicians.
For patients, clinicians, wellness programs, and community screening organizations, the connection between steroids and insulin resistance is worth understanding. It sits at the intersection of prevention, metabolic health, cardiovascular risk, and practical screening.
What is insulin resistance?
Insulin is the hormone that helps move glucose out of the bloodstream and into cells where it can be used or stored. Insulin resistance means the body’s cells do not respond as effectively to insulin as they should. To compensate, the body often produces more insulin. Over time, blood sugar control may worsen, and the risk of prediabetes, type 2 diabetes, and cardiometabolic problems can increase.
The CDC notes that insulin resistance is linked with high blood sugar, high triglycerides, high LDL cholesterol, and low HDL cholesterol. These are exactly the kinds of metabolic signals that make the topic relevant to people interested in cholesterol testing, cardiovascular screening, and preventive care.
Which steroids are most associated with insulin resistance?
When people say “steroids,” they often mean different things. In this context, the most clinically important group is corticosteroids, also called glucocorticoids. These include medications such as:
- prednisone
- prednisolone
- dexamethasone
- methylprednisolone
- hydrocortisone
These medications are widely prescribed because they reduce inflammation and suppress immune activity. But they are also well known to affect glucose metabolism. Reviews of glucocorticoid-induced hyperglycemia describe steroid-related increases in insulin resistance as a central mechanism.
This is the most evidence-based version of the statement “steroids cause insulin resistance.” More precisely, many commonly used corticosteroids can worsen insulin sensitivity and elevate blood sugar, especially at higher doses, with systemic use, or over longer periods.
How do steroids increase insulin resistance?
This is where the biology becomes important.
Clinical and mechanistic reviews show that glucocorticoids can disrupt normal glucose regulation in several ways. They can:
- Increase insulin resistance in tissues such as liver, muscle, and adipose tissue.
- Increase glucose production by the liver, which pushes more sugar into circulation.
- Reduce insulin secretion in some settings by impairing beta-cell function.
In plain language, steroids can make the body less responsive to insulin while also making it easier for glucose to rise. That is why clinicians use terms like steroid-induced hyperglycemia and steroid-induced diabetes.
Can steroids raise blood sugar even in people without diabetes?
Yes. That is one of the reasons this topic is so important.
A 2024 review notes that when glucocorticoids are given even to healthy subjects for short periods, impaired glucose tolerance with insulin resistance can be observed. Earlier reviews similarly describe glucocorticoids as increasing insulin resistance and triggering compensatory hyperinsulinemia in otherwise healthy individuals.
That does not mean every person who takes a steroid will develop diabetes. It does mean the effect is biologically real and clinically relevant.
Who is most at risk for steroid-induced insulin resistance?
Risk is not the same for every person. The likelihood of steroid-related blood sugar problems generally rises with factors such as:
- higher steroid dose
- longer duration of use
- systemic steroids rather than very limited local exposure
- existing prediabetes or diabetes
- family history of diabetes
- underlying metabolic risk factors
The CDC notes that prediabetes is already extremely common in the United States and often goes unrecognized. More than 2 in 5 adults have prediabetes, and about 8 in 10 people with prediabetes do not know they have it. That means many people may begin steroid treatment with pre-existing metabolic vulnerability.
The practical takeaway is straightforward: a steroid can be the added stressor that reveals an already fragile glucose-control system. That is an inference drawn from the high baseline prevalence of prediabetes and the documented metabolic effects of glucocorticoids.
Why this matters for cardiovascular health
At first glance, steroids and insulin resistance may sound like a diabetes-only issue. They are not.
Insulin resistance is closely tied to broader metabolic health and to cardiovascular risk patterns. The CDC specifically links insulin resistance with high triglycerides, higher LDL cholesterol, and lower HDL cholesterol. Prediabetes also raises the risk of heart disease and stroke.
That makes this topic highly relevant for an audience interested in cholesterol testing, preventive health, and point-of-care screening. Someone may come in thinking only about cholesterol, yet the larger issue may be metabolic dysfunction that includes blood sugar dysregulation and insulin resistance.
Common questions patients ask about steroids and blood sugar
“Do steroids always cause insulin resistance?”
No. Not everyone responds the same way. But corticosteroids are clearly associated with higher insulin resistance and higher blood sugar risk, especially in susceptible individuals.
“Is this only a problem with diabetes?”
No. It is especially important in people with prediabetes or diabetes, but steroid-related blood sugar changes can also occur in people without a prior diagnosis.
“Should someone stop taking prescribed steroids?”
No one should stop a prescribed medication without guidance from their clinician. The better question is whether blood sugar and related metabolic markers should be monitored during treatment.
“Are all steroids the same?”
No. The strongest clinical evidence here relates to glucocorticoids such as prednisone and dexamethasone. The term “steroids” is broad, so the specific medication matters.
Steroid-induced hyperglycemia and early detection
One reason this subject works well in health education is that it reinforces a practical point: numbers can reveal risk before symptoms do.
Peter Attia’s recent discussions continue to emphasize early detection of insulin resistance and metabolic health problems. That aligns well with the screening mindset. A person may feel “fine,” but objective data can show whether metabolism is starting to drift in the wrong direction.
This is especially useful in settings such as:
- community health screenings
- employer wellness events
- pharmacy testing programs
- clinician offices
- preventive cardiometabolic education programs
A cholesterol screen alone is not the whole story, but it can be an important entry point into a broader conversation about cardiometabolic risk.
What signs may suggest underlying insulin resistance?
The CDC notes that insulin resistance is associated with:
- high blood sugar
- high triglycerides
- high LDL cholesterol
- low HDL cholesterol CDC
For more information about monitoring cholesterol and triglycerides.